Yes, but caution is advised. Vardenafil can lower blood pressure, which may enhance the effect of antihypertensive drugs. Your prescriber should monitor your blood pressure and may adjust doses to avoid symptomatic hypotension.
The recommended window is 1-3 hours before intercourse. This allows both vardenafil and dapoxetine to reach peak concentrations, providing erection support and ejaculation delay.
A high-fat meal can delay the absorption of vardenafil, potentially postponing the onset of action. Taking the tablet with a light meal or on an empty stomach usually yields a quicker response.
As of the current UK market, no generic formulation of the fixed-dose vardenafil/dapoxetine tablet has received MHRA approval. Patients may obtain the individual generic components separately, but the combined product remains brand-specific.
Seek emergency medical care immediately. Prolonged erections (priapism) can cause permanent tissue damage if not promptly treated.
Mild hepatic impairment may be tolerated, but dosage reduction (e.g., lower vardenafil strength) is often recommended. Severe liver disease (Child-Pugh B/C) is a relative contraindication and requires specialist assessment.
St John’s wort induces CYP3A4, which can reduce vardenafil concentrations and diminish its effectiveness. Discuss all herbal and over-the-counter products with your clinician before use.
Excessive alcohol can impair erection quality and augment hypotensive effects of vardenafil. Moderate intake is generally acceptable, but heavy drinking should be avoided on the day of dosing.
Do not discard tablets in household waste. Participate in a local pharmacy-based take-back scheme or follow NHS guidelines for safe medication disposal.
Older men may be more sensitive to blood-pressure changes and visual disturbances. Starting with the standard dose is permissible, but clinicians often monitor closely and consider dose reduction if adverse effects arise.
The active ingredients are indicated for male sexual function. There is no approved or studied use for women, and the medication should not be taken by females.
The combined tablet provides a single, convenient dose, potentially improving adherence. Pharmacologically, the effects are similar to taking vardenafil and dapoxetine individually, but the fixed dose limits flexibility for dose adjustments.
Pills are not considered controlled substances in the UK, but it is advisable to keep them in their original packaging with a prescription label when travelling internationally. Declare them if required by the destination country's regulations.
Standard workplace drug screens typically do not test for PDE5 inhibitors or SSRIs. However, specific sports or safety-critical testing programs may have individual policies; consult the testing authority if concerned.
Levitra with Dapoxetine is a combination pill that contains two active pharmaceutical ingredients: vardenafil and dapoxetine. Vardenafil belongs to the class of phosphodiesterase-5 (PDE5) inhibitors and is approved in the United Kingdom for the treatment of erectile dysfunction (ED). Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that has received approval in several European countries for the management of premature ejaculation (PE). The product is supplied as a single oral tablet containing 20 mg vardenafil and 60 mg dapoxetine.
In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) registers medicines for specific therapeutic uses. While each ingredient has its own approved indication, the combined formulation - Levitra with Dapoxetine - has not received a separate marketing authorisation. Consequently, its use is considered off-label and should only be undertaken under the direct supervision of a qualified healthcare professional.
Vardenafil blocks the enzyme phosphodiesterase-5, which normally breaks down cyclic guanosine monophosphate (cGMP) in the penile smooth muscle. By inhibiting PDE5, vardenafil allows cGMP to accumulate, leading to relaxation of the smooth muscle, increased blood flow into the corpora cavernosa, and the ability to achieve and maintain an erection in response to sexual stimulation. The onset of action typically occurs within 30-60 minutes, with a duration of effect of up to 4-5 hours.
Dapoxetine selectively inhibits the re-uptake of serotonin (5-HT) at neuronal synapses, increasing serotonergic neurotransmission. In the context of premature ejaculation, heightened serotonin activity lengthens the ejaculatory latency time by modulating spinal reflex pathways that control ejaculation. Dapoxetine is rapidly absorbed, reaches peak plasma concentrations within 1-2 hours, and is eliminated largely within 24 hours, which allows on-demand dosing rather than daily administration.
When both agents are taken together, vardenafil addresses the inability to achieve a satisfactory erection, while dapoxetine aims to delay ejaculation, potentially offering a coordinated approach for men who experience both conditions simultaneously.
| Ingredient | Approved Indication in the UK | Typical Formulation | |||| | Vardenafil | Erectile dysfunction (MHRA-approved) | Tablets 5 mg, 10 mg, 20 mg | | Dapoxetine | Premature ejaculation (approved in several EU member states; not separately approved by the MHRA) | Tablets 30 mg, 60 mg |
Key Points
The combined pill does not possess a separate regulatory approval for any indication. Its use relies on the clinician’s judgment to address co-existing ED and PE.
The concurrent administration of vardenafil and dapoxetine in a single tablet is off-label in the UK. Limited peer-reviewed data exist on the efficacy and safety of this combination compared with taking each medication separately. Some small, open-label studies suggest that addressing both erection and ejaculation timing may improve overall sexual satisfaction, but robust randomized controlled trials are lacking.
Disclaimer: Off-label use of Levitra with Dapoxetine must be undertaken only after a thorough assessment of potential benefits, risks, and patient preferences. The prescribing clinician should discuss the limited evidence base and obtain informed consent.
If any of the above conditions are present, alternative therapies should be explored.
These reactions are generally mild, self-limiting, and may be mitigated by taking the tablet with a small amount of food and remaining well hydrated.
Any sudden visual changes, painful erection, or signs of severe allergic reaction (rash, swelling, difficulty breathing) should prompt immediate medical attention.
Patients should provide a complete medication list, including over-the-counter products and herbal supplements, before starting therapy.
Operating heavy machinery or driving is not typically restricted, but patients experiencing dizziness or visual disturbances should refrain until symptoms resolve.
Routine follow-up visits (every 3-6 months) help assess efficacy, tolerability, and any emerging safety concerns.
This article provides educational information about Levitra with Dapoxetine and is not a substitute for professional medical advice. Treatment decisions, including the use of off-label combinations, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
